Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease

…, K Sathananthan, R Fortescue - Cochrane Database of …, 2019 - cochranelibrary.com
Background Individuals with chronic bronchitis or chronic obstructive pulmonary disease (COPD)
may suffer recurrent exacerbations with an increase in volume or purulence of sputum, …

[HTML][HTML] The effects of step-count monitoring interventions on physical activity: systematic review and meta-analysis of community-based randomised controlled trials …

…, C Wahlich, R Fortescue, DG Cook, R Knightly… - International Journal of …, 2020 - Springer
Background Step-count monitors (pedometers, body-worn trackers and smartphone
applications) can increase walking, helping to tackle physical inactivity. We aimed to assess the …

Sublingual immunotherapy for asthma

R Fortescue, KM Kew… - Cochrane Database of …, 2020 - cochranelibrary.com
Background Asthma is a common long‐term respiratory disease affecting approximately
300 million people worldwide. Approximately half of people with asthma have an important …

European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis

AB Chang, R Fortescue, K Grimwood… - European …, 2021 - Eur Respiratory Soc
There is increasing awareness of bronchiectasis in children and adolescents, a chronic
pulmonary disorder associated with poor quality of life for the child/adolescent and their parents, …

[HTML][HTML] Clinical and research priorities for children and young people with bronchiectasis: an international roadmap

…, A Bush, JD Chalmers, R Fortescue… - ERJ Open …, 2021 - Eur Respiratory Soc
The global burden of children and young people (CYP) with bronchiectasis is being
recognised increasingly. They experience a poor quality of life and recurrent respiratory …

Phosphodiesterase‐4 inhibitors for chronic obstructive pulmonary disease

S Janjua, R Fortescue, P Poole - Cochrane Database of …, 2020 - cochranelibrary.com
Background Chronic obstructive pulmonary disease (COPD) is associated with cough,
sputum production or dyspnoea, and a reduction in lung function, quality of life, and life …

European Respiratory Society statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials

…, A Claydon, C Constant, R Fortescue… - European …, 2022 - Eur Respiratory Soc
Bronchiectasis is being diagnosed increasingly in children and adolescents. Recurrent
respiratory exacerbations are common in children and adolescents with this chronic pulmonary …

Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta‐analysis

…, AG Mathioudakis, R Fortescue… - Cochrane Database …, 2021 - cochranelibrary.com
Background Chronic obstructive pulmonary disease (COPD) is a chronic respiratory
condition characterised by persistent respiratory symptoms and airflow limitation. Acute …

Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD)

…, KC Pike, R Carr, A Coles, R Fortescue… - Cochrane Database …, 2021 - cochranelibrary.com
Background Chronic obstructive pulmonary disease (COPD) is a chronic lung condition
characterised by persistent respiratory symptoms and limited lung airflow, dyspnoea and …

Implementation of self-tuning regulators with variable forgetting factors

TR Fortescue, LS Kershenbaum, BE Ydstie - Automatica, 1981 - Elsevier
… Tim is observed as a quick growth of O~ r [a decrease of P(O]; however, as control ~ts better
one will find that OO r may become very small, especially in a Mar-deterministic system and …